Pages

▼
Showing posts with label process. Show all posts
Showing posts with label process. Show all posts
Sunday, 29 September 2013

ONE LAKH VIEWS ON ALL MY BLOGS--DR ANTHONY CRASTO

›
DR ANTHONY MELVIN CRASTO Ph.D WORLDDRUGTRACKER ANNOUNCING ONE LAKH PLUS VIEWS ON ALL BLOGS- DR ANTHONY CRASTO Eurekamoments in Orga...
Thursday, 26 September 2013

Primary pulmonary hypertension

›
Primary pulmonary hypertension from drvasudev007
Wednesday, 24 July 2013

Isis Phase II drug APOIIIRx slashes triglycerides by 64%

›
Isis Pharmaceuticals is "very encouraged" by a second set of mid-stage data for its heart drugAPOIIIRx, which shows that it ...
Tuesday, 23 July 2013

New therapy for pancreatic cancer: Phase III clinical trial currently recruiting Australian patients

›
Currently there is a clinical trial that is recruiting patients from around the globe including sites across Australia. The trial is test...
1 comment:

Phase III prostate cancer trial for 'homing' injection shows improvements

›
Phase III prostate cancer trial for 'homing' injection shows improvements A new treatment for advanced prostate cancer that ...
Monday, 22 July 2013

Anticancer agent – elacytarabin

›
Elacytarabine Cytarabine is a cytosine derivative that is a common component of chemotherapy regimens for blood cancers such as acut...

Cancer drug tested in pet dogs is now bound for human trials

›
PAC 1 Thanks to a new $2 million investment, a drug that spurs cancer cells to self-destruct while sparing healthy cells is on the road t...
Friday, 19 July 2013

Alkermes Adds Multiple Sclerosis Pill To Expanding Pipeline

›
Alkermes Adds Multiple Sclerosis Pill To Expanding Pipeline TheStreet.com The company expects to seek permission from FDA to begin human te...
Tuesday, 16 July 2013

Furiex Pharmaceuticals Announces Completion of Patient Enrollment for Its Phase III Clinical Trials of Eluxadoline for IBS-d

›
http://www.ama-assn.org/resources/doc/usan/eluxadoline.pdf   get the structure of eluxadoline here  name  Benzoic acid, 5-[[[(2S)-2-amin...
1 comment:
Saturday, 13 July 2013

Role of computers in drug design1

›
allow slideshare to load........... Role of computers in drug design1 from Educationcareer,authorstream  
Friday, 12 July 2013

Vical's Allovectin Phase III Trial Results: Consider The Possibilities

›
Vical's Allovectin Phase III Trial Results: Consider The Possibilities ... Cohen: We saw that happen last y...

Ohr Pharmaceutical Achieves 50% Enrollment Milestone in Squalamine Eye Drop Phase II Clinical Trial

›
squalamine July 10, 2013 / Ohr Pharmaceutical, Inc. , a pharmaceutical company focused on the development of novel therapeutics for la...
Thursday, 4 July 2013

Garlic in India

›
    Garlic in India The ancient Indians had varying views on garlic; but, for the most part, it was considered to be highly bene...

Chocolate as medicine: a quest over the centuries

›
The rehabilitation of chocolate has occurred only in recent times. The pages of scientific magazines have been positively recaptured and...
Monday, 1 July 2013

Verona Pharma Plc Peer-Reviewed Paper Suggests RPL554 With Glycopyrrolate, Or Other Muscarinic Receptor Antagonists, Produces Synergistic Bronchodilation

›
RPL554 Verona Pharma Plc ("Verona Pharma" Or The "Company") Peer-Reviewed ... Wall Street Journal Verona Pharm...
Friday, 28 June 2013

WORLD DRUG TRACKER | join LinkedIn Group

›
WORLD DRUG TRACKER   | LinkedIn in.linkedin.com/groups/ WORLD - DRUG - TRACKER -5055643 ‎ Jun 7, 2013 –   To track i...

Alexion’s Soliris® (eculizumab) Receives Orphan Drug Designation for the Treatment of Neuromyelitis Optica (NMO)

›
Structure of eculizumab . Eculizumab was engineered to reduce immunogenicity and eliminate effector function. Human IgG2 and IgG4 heav...

Celgene buys MophoSys for myeloma antibody development

›
Celgene buys MophoSys for myeloma antibody development German biopharmaceutical company MorphoSys will jointly develop an antibody for t...
Thursday, 27 June 2013

Novartis' Omalizumab Meets Phase III Endpoints

›
Novartis' Omalizumab Meets Phase II... Novartis reports new Phase III data showing omalizumab significantly... http://www.pharma...
Tuesday, 25 June 2013

How many modes of action should an antibiotic have?

›
Structures of resistance-breaking derivatives of established antibiotic classes. Selected compounds are depicted that were recently launc...